Screener
Viridian Therapeutics, Inc. VRDN Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001590750-26-000018
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Total current assets | 1,081,270 | 894,233 |
| Property and equipment, net | 2,765 | 1,228 |
| Operating lease right-of-use asset | 2,085 | 2,421 |
| Intangible asset, net | 10,000 | — |
| Other assets | 1,113 | 1,536 |
| Total assets | $1,097,233 | $899,418 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Viridian Therapeutics, Inc.'s intangibles (net)?
- Viridian Therapeutics, Inc. (VRDN) reported intangibles (net) of $10M in Q2 2026.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.
Ask your AI about Viridian Therapeutics, Inc.'s intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude